MZ

Mo Zhao

Equity Analyst at Orbis Investments

London Area, United Kingdom

Overview

Work Experience

OI

Orbis Investments

  • Equity Analyst

    2024 - Current

    Healthcare investment

OI

Orbis Investments

  • Equity Analyst Intern

    2023 - 2023

6D

6 Dimensions Capital

  • Associate

    2020 - 2022

    6 Dimensions Capital is a leading healthcare-focused, cross-border VC in China with $2.3 billion AUM. Portofolio include Grail, Viela Bio, OcuMension, Brii Biosciences, CStone and many others. -My responsibilities at 6DC include venture formation, early stage deal sourcing and due dilligence, as well as portofolio support in the biotech and pharma sector. -Core deal team member of Cutia Therapeutics (HKEX ticker: 2487.HK), Ignis Therapeutics ($180m series A, one of the largest in China pharma sector) and a stealth mode biotech focused on next-gen protein therapeutics ($20m pre-A raise) https://www.cutiatx.com/ https://www.dealstreetasia.com/stories/ignis-funding-269621

  • Analyst

    2019 - 2020

  • Analyst Intern

    2019 - 2019

LC

Legend Capital

  • Analyst Intern

    2018 - 2019

    Healthcare investment team intern

IF

Innovation Forum

  • Vice President Of Business Development

    2017 - 2018

    -With a team delivered five conferences with over 100 attendees. -With a team delivered the annual ImagineIF start-up competition, attracted over 20 local applicants. -Worked in the core team and delivered a global biomedical innovation conference, with over 500 delegates.

Education

Relevant Websites